You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Patent: 5,693,027


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,693,027
Title: Adaptor top
Abstract:A plastic top for adapting to a chosen syringe (14) a standard cartridge (8) of the kind having a neck (9) with a flange (10) and being closed by a rubber membrane (11) sealingly secured against the flange (10) by a metal cover (12) having its edge beaded behind the flange. This plastic top has a bore (2) for receiving the neck part (9) of the cartridge (8), which bore (2) has a diameter making it fit over the metal cover (12) and is provided with protrusions (3;9) gripping behind the edge of the metal cover (12) when the neck part (9) is inserted in the bore. The outer contour of the plastic top is adapted to the syringe type in which the cartridge is going to be used. The plastic top is provided with a thread (5;18) coaxial with the bore to receive a needle hub (13) in a way making its needle (15) penetrate the membrane (11) of the cartridge (8) when the hub (13) is mounted on the thread (5) of the plastic top.
Inventor(s): Hansen; Ib (Herlev, DK), Mikkelsen; S.o slashed.ren (Holte, DK), Bonnichsen; Frits Frydendal (Lynge, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/313,651
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 5,693,027

Introduction

United States Patent 5,693,027, though not specifically detailed in the provided sources, can be analyzed through a general understanding of patent law, the patent application process, and the tools available for evaluating patent claims. This article will provide a comprehensive and critical analysis of the claims and the patent landscape, using relevant principles and examples from U.S. patent law.

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention for which protection is sought. These claims must meet the criteria of novelty, non-obviousness, and usefulness as outlined in U.S. patent law[2].

Novelty Requirement

For a patent claim to be valid, the claimed invention must be novel, meaning it must not have been patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention[2]. Analyzing the prior art, which includes all information available to the public at the time of the patent application, is crucial in determining novelty.

Nonobviousness Requirement

Even if a claimed invention is novel, it must also be non-obvious. This means that the invention must be significantly different from existing technology and not an obvious improvement over what is already known[2]. The examiner must determine whether the claims overcome the technical features disclosed in the prior art.

Usefulness Requirement

The invention must also be useful, meaning it must have a practical application. This requirement is often less contentious but still an essential part of the patentability criteria.

The Patent Application Process

The process of obtaining a patent involves a detailed discussion between the patent applicant and the patent office examiner, which is documented in the patent file wrapper or prosecution history. This file wrapper includes all communications, arguments, and decisions made during the application process and becomes publicly available 18 months after the initial filing[3].

Analyzing the Patent File Wrapper

To critically analyze the claims of a patent like 5,693,027, one would need to review the patent file wrapper. This document contains the specific arguments made between the applicant and the examiner, including any rejections, amendments, and the final decision to issue the patent. For example, if claims were rejected under 35 U.S.C. § 102(a)(1) or § 102(a)(2) for being anticipated by prior art, this would be detailed in the file wrapper[3].

Inter Partes Review and Patent Trial and Appeal Board (PTAB)

After a patent is granted, its validity can still be challenged through administrative processes such as Inter Partes Review (IPR) and Post-Grant Review (PGR) before the Patent Trial and Appeal Board (PTAB). These processes, established by the Leahy-Smith America Invents Act (AIA), provide a faster and less expensive way to challenge patent validity compared to judicial proceedings[2].

Terminal Disclaimers and Obviousness-Type Double Patenting

In cases where multiple patents are filed for related inventions, terminal disclaimers may be used to avoid obviousness-type double patenting rejections. The USPTO has proposed rules that condition the enforceability of claims in terminally disclaimed continuation patents on the validity of precedent claims, ensuring that the patent landscape remains clear and consistent with statutory and case law[1].

Impact of AI on Patent Applications

With the increasing use of AI tools in patent drafting, it is crucial to disclose any material contributions made by AI systems to the USPTO. This includes assessing whether the contributions made by natural persons rise to the level of inventorship and ensuring that all documents prepared with AI assistance are accurate and do not omit material information[5].

Competitive Intelligence and Patent Landscaping

Patent file wrappers and other public documents can be used for competitive intelligence, providing valuable insights into the strategies and challenges faced by other inventors and companies. This information can help in making informed decisions about patent filings and litigation strategies[3].

Key Considerations for Patent Holders

  • Flexibility in Claim Management: Patent applicants have various tools to manage their claims, including reissuance and the use of terminal disclaimers, to ensure their inventions are adequately protected[1].
  • Compliance with USPTO Guidelines: Ensuring compliance with USPTO guidelines, especially regarding the use of AI tools, is essential to maintain the validity of the patent[5].
  • Monitoring and Challenging Patents: Keeping an eye on the patent landscape and using mechanisms like IPR and PGR can help in challenging or defending patents effectively[2].

Case Law and Statutory Consistency

The validity of patent claims must align with statutory requirements and case law. For instance, the USPTO’s authority to impose conditions on terminal disclaimers is supported by case law such as In re Van Ornum and statutory provisions like 35 U.S.C. § 253(a)[1].

Conclusion

Analyzing the claims and patent landscape of a specific patent like 5,693,027 involves a thorough review of the patent file wrapper, compliance with patentability criteria, and an understanding of the broader patent law framework. This includes considering the role of administrative challenges, the impact of AI on patent applications, and the strategic use of terminal disclaimers.

Key Takeaways

  • Patent Claims Must Meet Novelty, Nonobviousness, and Usefulness Criteria: These are fundamental requirements for patent validity.
  • Patent File Wrappers Provide Valuable Insights: They detail the application process and arguments made during prosecution.
  • Administrative Challenges Can Impact Patent Validity: IPR and PGR processes can be used to challenge patents post-grant.
  • AI Contributions Must Be Disclosed: Ensuring transparency in the use of AI tools is crucial for maintaining patent validity.
  • Terminal Disclaimers Can Manage Double Patenting Issues: They help in avoiding obviousness-type double patenting rejections.

FAQs

Q: What are the key criteria for patentability in the United States? A: The key criteria are novelty, non-obviousness, and usefulness.

Q: How can the validity of a granted patent be challenged? A: The validity can be challenged through Inter Partes Review (IPR) and Post-Grant Review (PGR) before the Patent Trial and Appeal Board (PTAB).

Q: What is the role of a patent file wrapper in patent analysis? A: The patent file wrapper contains detailed communications between the applicant and the examiner, providing insights into the application process and the arguments made during prosecution.

Q: How does the use of AI tools impact patent applications? A: AI tools must be disclosed if their contributions are material to patentability, and practitioners must ensure the accuracy of documents prepared with AI assistance.

Q: What are terminal disclaimers, and how do they affect patent enforceability? A: Terminal disclaimers are used to avoid double patenting issues and condition the enforceability of claims in continuation patents on the validity of precedent claims.

Sources

  1. Letterhead DC Office - Regulations.gov
  2. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service
  3. Patent file wrappers as a tool for competitive intelligence - IP Checkups
  4. US10213559B2 - Drug delivery device with brake mechanism - Google Patents
  5. U.S. Patent Office Issues Additional Guidance on Use of AI Tools - Buchanan Ingersoll & Rooney

More… ↓

⤷  Try for Free

Details for Patent 5,693,027

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 25, 1991 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 June 01, 2018 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 June 07, 2000 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 January 19, 2001 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 April 23, 2004 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLOG insulin aspart Injection 020986 October 31, 2013 ⤷  Try for Free 2014-12-02
Novo Nordisk Inc. NOVOLOG MIX 70/30 insulin aspart protamine and insulin aspart Injectable Suspension 021172 November 01, 2001 ⤷  Try for Free 2014-12-02
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 7 of 7 entries

International Patent Family for US Patent 5,693,027

CountryPatent NumberEstimated Expiration
Australia 6617390 ⤷  Try for Free
Australia 8544191 ⤷  Try for Free
Australia 8648491 ⤷  Try for Free
Austria 123418 ⤷  Try for Free
Austria E109667 ⤷  Try for Free
Austria E114978 ⤷  Try for Free
China 1029663 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.